We're so glad you're here! This site is to help anyone diagnosed with Medullary Thyroid Cancer and their caregivers find valuable information and support. If you'd like to connect with others with MTC, please consider joining our very active Facebook Group. You don't have to go through this alone!
If you don't yet have a copy, please download the American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma, aka "The Guidelines." This is the MTC Bible. Read it and know it and it will help you and your doctor ensure you get the proper treatment.
Lastly, please consider looking into being seen by an MTC expert. We do our best to keep a running list of what we call "Centers of Excellence." These are doctors and facilities that are properly trained and experienced enough to treat MTC patients. It's one of the most important decisions you can make on your journey.
"Retevmo (selpercatinib; RET kinase inhibitor): In a late-breaking Plenary Session presentation, Lilly will report primary event-free survival results ..."
"CStone Pharmaceuticals (SEHK:2616) has announced the first domestically produced batch of pralsetinib capsules in China, starting nationwide ..."
"People With Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia Syndrome Type 2 ...Read more loss. However, like many potent medications ..."
"... EP0031,), a next-generation selective RET inhibitor (SRI), from a pivotal registrational Phase study in patients with advanced RET ..."
"Who this is not for: People with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should ..."
This website is intended for educational purposes only. It is not intended, nor should it be interpreted, as medical advice or instructions of any kind. Readers are advised to consult their own medical doctor(s) for all matters involving their health and medical care.